The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System  M.E.A. de Kraker, V. Jarlier,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.
Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013  J. Verschueren, L. Cnops,
G. Cornaglia, A. Lönnroth, M. Struelens 
Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period  J. Liñares, C. Ardanuy, R. Pallares, A.
Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain  A. Rivera, M. Rebollo, F. Sánchez, F. Navarro,
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys 
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.
J.-P. Van geertruyden  Clinical Microbiology and Infection 
N. Messad, L. Landraud, B. Canivet, G. Lina, J. -L. Richard, A
Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98  J. Robert, E. Cambau, K. Grenet, D.
R. Cantón  Clinical Microbiology and Infection 
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program  M.
Characterizing non-linear effects of hospitalisation duration on antimicrobial resistance in respiratory isolates: an analysis of a prospective nationwide.
Genome-based insights into the evolution of enterococci
Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit  K. Thorburn,
Clinical Microbiology and Infection
Surveillance of Legionnaires’ disease in Austria
A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals  M. Nagao  Clinical Microbiology and.
D.E. Low  Clinical Microbiology and Infection 
Pharmacodynamics of doxycycline
Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.
Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern.
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Human health risks associated with antimicrobial-resistant enterococci and Staphylococcus aureus on poultry meat  V. Bortolaia, C. Espinosa-Gongora, L.
Replacement of methicillin-resistant Staphylococcus aureus clones in Hungary over time: a 10-year surveillance study  T. Conceição, M. Aires-de-Sousa,
Good epidemiological practice: a narrative review of appropriate scientific methods to evaluate the impact of antimicrobial stewardship interventions 
D. Esel, B. Sümerkan, S. Kocagöz  Clinical Microbiology and Infection 
Population structure analyses of Staphylococcus aureus at Tygerberg Hospital, South Africa, reveals a diverse population, a high prevalence of Panton–Valentine.
Microbiological and epidemiological studies of Enterococcus faecium resistant to amoxycillin in a university hospital in eastern France  M. Thouverez,
Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region  K.B. Laupland, M.D. Parkins, T. Ross, J.D.D. Pitout 
M. Aires-de-Sousa  Clinical Microbiology and Infection 
The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae  J.M. Sierra,
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features  A.
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Evolving problems with resistant pathogens
Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
C. Gagliotti, L. Nobilio, M.L. Moro 
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
Catheter-related bloodstream infection caused by Enterococcus spp.
G.M. Rossolini, E. Mantengoli  Clinical Microbiology and Infection 
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
J.-M. Rolain, C. Abat, P. Brouqui, D. Raoult 
Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013  A. Badura, G. Feierl, G. Pregartner,
Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting  A. Kronenberg, S. Koenig, S. Droz,
Clinical and molecular epidemiology of chromosome-mediated resistance to third- generation cephalosporins in Enterobacter isolates in eastern France  D.
The atypical pneumonias: clinical diagnosis and importance
C. Novais, T.M. Coque, J.C. Sousa, L.V. Peixe 
New oral cephalosporins in pediatric community-acquired infections
J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory 
O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger 
Antibiotic overconsumption and resistance in Turkey
B.A. Cunha  Clinical Microbiology and Infection 
European recommendations for antimicrobial resistance surveillance
J.L. Balcázar  Clinical Microbiology and Infection 
Test results: characterising the antimicrobial activity of daptomycin
G.C. Schito  Clinical Microbiology and Infection 
L. Blairon, Y. De Gheldre, B. Delaere, A. Sonet, A. Bosly, Y
G. Kahlmeter  Clinical Microbiology and Infection 
High prevalence of mutators among Enterobacter cloacae nosocomial isolates and their association with antimicrobial resistance and repetitive detection 
The future of diagnostic bacteriology
Presentation transcript:

The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System  M.E.A. de Kraker, V. Jarlier, J.C.M. Monen, O.E. Heuer, N. van de Sande, H. Grundmann  Clinical Microbiology and Infection  Volume 19, Issue 9, Pages 860-868 (September 2013) DOI: 10.1111/1469-0691.12028 Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Trends in the total number of Staphylococcus aureus, Escherichia coli, Streptococcus pneumoniae, Enterococcus faecium and Enterococcus faecalis bacteraemia isolates reported to the European Antimicrobial Resistance Surveillance System between 2002 and 2008. Only laboratories that consistently reported for all years were included. Clinical Microbiology and Infection 2013 19, 860-868DOI: (10.1111/1469-0691.12028) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Total number of Escherichia coli bacteraemia isolates with different resistance phenotypes reported to the European Antimicrobial Resistance Surveillance System between 2002 and 2008. Only laboratories that consistently reported for all years were included. R = resistance; G3C = third-generation cephalosporins; FQ = fluoroquinolones; amipn = aminopenicillins. For reasons of clarity, combined resistance proportions for aminoglycosides are exclusively displayed in a Table. Clinical Microbiology and Infection 2013 19, 860-868DOI: (10.1111/1469-0691.12028) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 3 Relative increase in the number of Escherichia coli bacteraemia isolates with different resistance phenotypes (index year = 2002) reported to the European Antimicrobial Resistance Surveillance System between 2002 and 2008. Only laboratories that consistently reported for all years were included. Symbols indicate ascertained values and lines are based on generalized linear models with Poisson distribution. Numbers and the average annual increase per phenotype are displayed in the table. R = resistance; G3C = third-generation cephalosporins; FQ = fluoroquinolones; amino = aminoglycosides; amipn = aminopenicillins. Clinical Microbiology and Infection 2013 19, 860-868DOI: (10.1111/1469-0691.12028) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions